A random-effects model was used to determine the diagnostic accuracy of serum CHI3L1 for diagnosing stages of liver fibrosis, because heterogeneity (I2 values for sensitivity, specificity, PLR, NLR, and DOR) for fibrosis stages F2, F3, and F4 was greater than 50%. This evidence concerns the gene CHI3L1 and fibrosis.